AstraZeneca PLC (AZN) reports a robust 21% revenue increase for 2024, while navigating market challenges and strategic ...

Q4 2024 Earnings Call Transcript February 6, 2025 AstraZeneca PLC misses on earnings expectations. Reported EPS is $1.05 EPS, ...

AstraZeneca unveiled both its fourth-quarter and full-year 2024 results before market open today, revealing that its total revenue was $14.89 billion. This represented a meaty 24% improvement over Q4 ...

This week was loaded with earnings releases of many large drugmakers. Novo Nordisk NVO, Merck MRK, Pfizer PFE, Eli Lilly LLY, ...

Sanofi has agreed to purchase its own shares worth €2bn ($2.08bn), part of a $5.1bn share buyback initiative in 2025.

If the trial is successful, the firm's complete estrogen receptor antagonist would complement its other biomarker-driven breast cancer assets.

Amazon faced ~900 Mn FX headwind in 4Q’24 which was ~700 mn higher than assumed. For the third consecutive quarter, AWS grew ...

This week was loaded with earnings releases of many large drugmakers. Novo Nordisk NVO, Merck MRK, Pfizer PFE, Eli Lilly LLY, AstraZeneca AZN and AbbVie announced their fourth-qua ...

The company plans to allocate a record amount to capital expenditures to build artificial-intelligence infrastructure.

The manufacturer has moved to a four day working week and says it is now rebuilding market share following a challenging ...

AstraZeneca may have exited the COVID-19 vaccine ... Pemgarda to make sales of between $150 million and $200 million in 2024. GSK has filed a pair of lawsuits against Moderna, claiming ...

This is because analysts at Morgan Stanley see rising headwinds on the demand side, which has been their key reason for cutting their Q4 oil price forecast. “The recent trajectory of oil prices ...